Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the first patients have been enrolled in an investigational device exemption (IDE) clinical trial evaluating... Read More

Tuesday July 31, 2018 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, P-15L Peptide Enhanced Bone Graft